** = Publications listed in SCI/SSCI/Pubmed
** Gotz, J; Petutschnigg, B; Wasler, A; Wran-Schumer, D; Hansak, P
Bystander resuscitation as a measure of success
NOTFALL RETTUNGSMED. 2017; 20(6): 470-476.
Doi: 10.1007/s10049-016-0256-4
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Heblich, F; Albrecht, K; Hein, S; Petutschnigg, B
Crew member of a cruise ship with exacerbated COPD
FLUGMEDIZIN TROPENME. 2017; 24(4): 167-169.
Doi: 10.1055/s-0043-117258
Web of Science
FullText
FullText_MUG
** Grasser, B; Iberer, F; Schreier, G; Schaffellner, S; Kastner, P; Prenner, G; Hipmair, G; Wasler, A; Petutschnigg, B; Müller, H; Hutten, H; Schaldach, M; Tscheliessnigg, K
Intramyocardial electrogram variability in the monitoring of graft rejection after heart transplantation.
Pacing Clin Electrophysiol. 1998; 21(11 Pt 2):2345-2349
Doi: 10.1111/j.1540-8159.1998.tb01179.x
Web of Science
PubMed
FullText
FullText_MUG
** Iberer, F; Grasser, B; Schreier, G; Schaffellner, S; Prenner, G; Allmayer, T; Wasler, A; Petutschnigg, B; Müller, H; Kastner, P; Schaldach, M; Hutten, H; Tscheliessnigg, KH
Introducing a new clinical method for noninvasive rejection monitoring after heart transplantation to clinical practice: analysis of paced intramyocardial electrograms.
Transplant Proc. 1998; 30(3):895-899
Doi: 10.1016%2FS0041-1345%2898%2900089-X
Web of Science
PubMed
FullText
FullText_MUG
** Iberer, F; Grasser, B; Schreier, G; Prenner, G; Schaffellner, S; Allmayer, T; Wasler, A; Petutschnigg, B; Müller, H; Hutten, H; Schaldach, M; Tscheliessnigg, KH
Noninvasive rejection monitoring after heart transplant.
TRANSPLANT PROC. 1997; 29(7): 3126-3126.
Doi: 10.1016%2FS0041-1345%2897%2900810-5
Web of Science
PubMed
FullText
FullText_MUG
** Egger, G; Allmayer, T; Iberer, F; Tscheliessnigg, KH; Auer, T; Wasler, A; Petutschnigg, B
Impaired Polymorphonuclear Leukocyte Migration as a Possible Monitor for the Risk of Septicemia in Immunosuppressed Transplant Patients
MED SCI RES 1996 24: 17-19.
Web of Science
** Grasser, B; Schreier, G; Iberer, F; Wasler, A; Petutschnigg, B; Müller, H; Prenner, G; Hipmair, G; Hutten, H; Schaldach, M; Tscheliessnigg, KH
Noninvasive monitoring of rejection therapy based on intramyocardial electrograms after orthotopic heart transplantation.
Transplant Proc. 1996; 28(6):3276-3277
Web of Science
PubMed
** Auer, T; Khoschsorur, GA; Rabl, H; Iberer, F; Petutschnigg, B; Wasler, A; Tscheliessnigg, KH
Detection of lipid peroxidation products by malondialdehyde (MDA-TBA reaction) in organ transplantation.
Transplant Proc. 1995; 27(5):2749-2751
Web of Science
PubMed
** Auer, T; Schreier, G; Hutten, H; Schaldach, M; Iberer, F; Petutschnigg, B; Wasler, A; Müller, H; Allmeyer, T; Tscheliessnigg, KH
Intramyocardial electrograms for monitoring of allograft rejection after heart transplantation.
Transplant Proc. 1995; 27(3):1983-1985
Web of Science
PubMed
** Auer, T; Schreier, G; Hutten, H; Tscheliessnigg, KH; Allmayr, T; Grasser, B; Iberer, F; Wasler, A; Petutschnigg, B; Müller, H
Intramyocardial electrograms for the monitoring of allograft rejection after heart transplantation using spontaneous and paced beats.
Transplant Proc. 1995; 27(5):2621-2624
Web of Science
PubMed
** Iberer, F; Tscheliessnigg, K; Halwachs, G; Auer, T; Wasler, A; Petutschnigg, B; Schreier, G; Müller, H; Allmayer, T; Prenner, G
Cytomegalovirus after heart transplantation: definitions for the guidance of antiviral therapy.
Scand J Infect Dis Suppl. 1995; 99(3):100-103
Web of Science
PubMed
** Iberer, F; Tscheliessnigg, KH; Halwachs, G; Auer, T; Wasler, A; Petutschnigg, B; Müller, H; Freigassner, M; Allmayr, T; Hipmair, G
CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
Wien Klin Wochenschr. 1995; 107(23):718-722
Web of Science
PubMed
** Wasler, A; Iberer, F; Auer, T; Petutschnigg, B; Müller, H; Pfeifer, J; Deutsch, T; Tscheliessnigg, KH
Treatment of leukopenia with granulocyte-macrophage colony-stimulating factor after heart transplantation.
Transplant Proc. 1995; 27(5):2633-2634
Web of Science
PubMed
** Iberer, F; Tscheliessnigg, KH; Freigassner, M; Auer, T; Kleinert, R; Wasler, A; Petutschnigg, B; Müller, H
Clinical experience with a monoclonal interleukin-2 receptor antibody (BT 563) for rejection therapy after orthotopic heart transplantation.
Transplant Proc. 1994; 26(6):3237-3239
Web of Science
PubMed
** Iberer, F; Vujicic, R; Rödl, S; Wasler, A; Sabin, K; Koshsorur, A; Allmayer, T; Auer, T; Petutschnigg, B; Tscheliessnigg, KH
Effects of prostaglandin E1 therapy on cyclosporine A and creatinine levels after orthotopic heart transplantation.
Transplant Proc. 1994; 26(6):3246-3248
Web of Science
PubMed
** Wasler, A; Petutschnigg, B; Iberer, F; Auer, T; Tscheliessnigg, KH
[Noninvasive monitoring of rejection in heart transplant patients. An overview of current status and use at a small transplant center].
Wien Klin Wochenschr. 1991; 103(4):105-110
Web of Science
PubMed